S1179 Bulevirtide Monotherapy at Low and High Dose in Patients With Chronic Hepatitis Delta: 24-Week Interim Data of the Phase 3 MYR301 Study
Year: 2022
Type: article
Authors: Stacey Lee, Heiner Wedemeyer, Soo Aleman, Maurizia Brunetto, Antje Blank, Pietro Andreone, Pavel Bogomolov, Vladimir Chulanov, Nina Mamonova, Natalia Geyvandova, Viacheslav Morozov, Olga Sagalova, Tatyana Stepanova, Dmitry Manuilov, Vithika Suri, Qi An, John F. Flaherty, Anu Osinusi, Julian Schulze zur Wiesch, Markus Cornberg, Stefan Zeuzem, Pietro Lampertico
Institutions: Medizinische Hochschule Hannover, Karolinska University Hospital, Karolinska Institutet, University of Pisa, Azienda Ospedaliera Universitaria Pisana, University Hospital Heidelberg, University of Modena and Reggio Emilia, Ministry of Health of the Russian Federation, Chelyabinsk State Medical Academy, Gilead Sciences (United States), University Medical Center Hamburg-Eppendorf, University Hospital Frankfurt, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4316080146